Clinical Trial

Efficacy of Stromal Vascular Fraction Versus Platelet Rich Plasma in Treatment of Androgenitic Alopecia

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 16, 2024 (before its estimated October 1, 2024 completion). Its status may not reflect the trial's current state.
Summary
The goal of this randomized controlled clinical trial is to test the efficacy \& safety of stromal vascular fraction in treatment of AGA \& compare it to PRP The main questions it aims to answer are: * efficacy \& safety of SVF for treatment of AGA patients * comparing it to PRP in treatment of AGA Participants will receive a single session of SVF in one half of the scalp \& a single session of PRP in the other half.
Trial Details
NCT Number NCT06558565
Lead Sponsor Kasr El Aini Hospital
Conditions Androgenetic Alopecia
Enrollment 20 participants
Start Date 2024-08-30
Primary Completion 2024-10-01 (estimated)
Study Completion 2025-04-01 (estimated)
Updated on ClinicalTrials.gov 2024-08-16